Elisabetta Gazzerro
YOU?
Author Swipe
View article: Genetic Deletion of the Purinergic Receptor <i>P2rx7</i> Worsens the Phenotype of α-Sarcoglycan Muscular Dystrophy
Genetic Deletion of the Purinergic Receptor <i>P2rx7</i> Worsens the Phenotype of α-Sarcoglycan Muscular Dystrophy Open
Limb-girdle muscular dystrophy R3 (LGMDR3), a rare genetic disorder characterized by progressive impairment of limb, diaphragmatic, and respiratory muscles, is caused by loss-of-function mutations in the α-sarcoglycan gene (SGCA) an…
View article: Undetected Neuromuscular Disease in Patients after Heart Transplantation
Undetected Neuromuscular Disease in Patients after Heart Transplantation Open
(1) Heart transplantation (HTX) improves the overall survival and functional status of end-stage heart failure patients with cardiomyopathies (CMPs). The majority of CMPs have genetic causes, and the overlap between CMPs and inherited myop…
View article: Caveolin-3 and Caveolin-1 Interaction Decreases Channel Dysfunction Due to Caveolin-3 Mutations
Caveolin-3 and Caveolin-1 Interaction Decreases Channel Dysfunction Due to Caveolin-3 Mutations Open
Caveolae constitute membrane microdomains where receptors and ion channels functionally interact. Caveolin-3 (cav-3) is the key structural component of muscular caveolae. Mutations in CAV3 lead to caveolinopathies, which result in both mus…
View article: “suMus,” a novel digital system for arm movement metrics and muscle energy expenditure
“suMus,” a novel digital system for arm movement metrics and muscle energy expenditure Open
Objective: In the field of non-treatable muscular dystrophies, promising new gene and cell therapies are being developed and are entering clinical trials. Objective assessment of therapeutic effects on motor function is mandatory for econo…
View article: Aberrant Adenosine Triphosphate Release and Impairment of P2Y2-Mediated Signaling in Sarcoglycanopathies
Aberrant Adenosine Triphosphate Release and Impairment of P2Y2-Mediated Signaling in Sarcoglycanopathies Open
View article: Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy
Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy Open
Nothing is known about the potential implication of gut microbiota in skeletal muscle disorders. Here, we provide evidence that fecal microbiota composition along with circulating levels of short‐chain fatty acids (SCFAs) and related metab…
View article: Telemedicine in Neuromuscular Diseases During Covid-19 Pandemic: ERN-NMD European Survey
Telemedicine in Neuromuscular Diseases During Covid-19 Pandemic: ERN-NMD European Survey Open
Background: Telemedicine (TM) contributes to bridge the gap between healthcare facilities and patients’ homes with neuromuscular disease (NMD) because of mobility issues. However, its deployment is limited due to difficulties evaluating su…
View article: P2X7 Receptor Antagonist Reduces Fibrosis and Inflammation in a Mouse Model of Alpha-Sarcoglycan Muscular Dystrophy
P2X7 Receptor Antagonist Reduces Fibrosis and Inflammation in a Mouse Model of Alpha-Sarcoglycan Muscular Dystrophy Open
Limb-girdle muscular dystrophy R3, a rare genetic disorder affecting the limb proximal muscles, is caused by mutations in the α-sarcoglycan gene (Sgca) and aggravated by an immune-mediated damage, finely modulated by the extracellular (e)A…
View article: Role of Extracellular ATP in the Progression of Muscle Damage in Sarcoglycanopathies
Role of Extracellular ATP in the Progression of Muscle Damage in Sarcoglycanopathies Open
Limb Girdle Muscular Dystrophy 2D (LGMD2D) is an inherited disorder characterized by progressive weakness and degeneration of skeletal muscle, loss of ambulation, respiratory insufficiency and, often, premature death. The disease results f…
View article: eATP/P2X7R Axis: An Orchestrated Pathway Triggering Inflammasome Activation in Muscle Diseases
eATP/P2X7R Axis: An Orchestrated Pathway Triggering Inflammasome Activation in Muscle Diseases Open
In muscle ATP is primarily known for its function as an energy source and as a mediator of the “excitation-transcription” process, which guarantees muscle plasticity in response to environmental stimuli. When quickly released in massive co…
View article: Table of Contents
Table of Contents Open
View article: The Danger Signal Extracellular ATP Is Involved in the Immunomediated Damage of α-Sarcoglycan–Deficient Muscular Dystrophy
The Danger Signal Extracellular ATP Is Involved in the Immunomediated Damage of α-Sarcoglycan–Deficient Muscular Dystrophy Open
View article: Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy
Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy Open
View article: Effects of non‐euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice
Effects of non‐euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice Open
Background and Purpose Duchenne muscular dystrophy (DMD), caused by dystrophin deficiency, results in chronic inflammation and irreversible skeletal muscle degeneration. Moreover, the associated impairment of autophagy greatly contributes …
View article: Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism
Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism Open
View article: Clinical and molecular consequences of exon 78 deletion in DMD gene
Clinical and molecular consequences of exon 78 deletion in DMD gene Open
View article: Generation of human induced pluripotent stem cells (EURACi001-A, EURACi002-A, EURACi003-A) from peripheral blood mononuclear cells of three patients carrying mutations in the CAV3 gene
Generation of human induced pluripotent stem cells (EURACi001-A, EURACi002-A, EURACi003-A) from peripheral blood mononuclear cells of three patients carrying mutations in the CAV3 gene Open
View article: 1st International Workshop on Clinical trial readiness for sarcoglycanopathies 15–16 November 2016, Evry, France
1st International Workshop on Clinical trial readiness for sarcoglycanopathies 15–16 November 2016, Evry, France Open
View article: The ubiquitin ligase tripartite-motif-protein 32 is induced in Duchenne muscular dystrophy
The ubiquitin ligase tripartite-motif-protein 32 is induced in Duchenne muscular dystrophy Open
View article: Gap Junctions and Epileptogenesis: No Laughing Matter
Gap Junctions and Epileptogenesis: No Laughing Matter Open
Hypothalamic hamartoma (HH) is a rare (about 1:100,000) developmental, non-neoplastic malformation involving the small hypothalamic area located between the infundibular stalk and the mammillary bodies (Maixner, 2006Maixner W. Hypothalamic…
View article: The leukodystrophy protein FAM126A (hyccin) regulates PtdIns(4)P synthesis at the plasma membrane
The leukodystrophy protein FAM126A (hyccin) regulates PtdIns(4)P synthesis at the plasma membrane Open
View article: Enhancement of Muscle T Regulatory Cells and Improvement of Muscular Dystrophic Process in mdx Mice by Blockade of Extracellular ATP/P2X Axis
Enhancement of Muscle T Regulatory Cells and Improvement of Muscular Dystrophic Process in mdx Mice by Blockade of Extracellular ATP/P2X Axis Open